Oxidative Stress in Alzheimer’s Disease: Should We Keep Trying Antioxidant Therapies?

Oxidative Stress in Alzheimer’s Disease: Why Did Antioxidant Therapy Fail?

(2014) Torbjörn Persson et al.   Oxidative Medicine and Cellular Longevity

Antioxidants for Alzheimer Disease

(2012) Douglas R. Galasko et al.   ARCHIVES OF NEUROLOGY

Ascorbic acid, cognitive function, and Alzheimer's disease: A current review and future direction

(2012) Gene L. Bowman   BIOFACTORS

Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine

(2012) Gao-Shang Chai et al.   JOURNAL OF NEUROCHEMISTRY

Rivastigmine Dermal Patch Solves Eating Problems in an Individual with Advanced Alzheimer's Disease

(2012) Chika Uwano et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial

(2012) Bruno Vellas et al.   LANCET NEUROLOGY

Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease

(2012) Sönke Arlt et al.   NEUROCHEMICAL RESEARCH

Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

(2012) Robert A DiSilvestro et al.   Nutrition Journal

Antioxidant Therapies for Alzheimer's Disease

(2012) Ye Feng et al.   Oxidative Medicine and Cellular Longevity

Induction of Neuronal Death by Microglial AGE-Albumin: Implications for Alzheimer’s Disease

(2012) Kyunghee Byun et al.   PLoS One

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

(2012) John M Ringman et al.   Alzheimers Research & Therapy

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

(2011) P. Hemachandra Reddy   BRAIN RESEARCH

A Novel Perspective on Tau in Alzheimers Disease

(2011) D. J. Bonda et al.   Current Alzheimer Research

Misfolded Truncated Protein   Induces Innate Immune Response via MAPK Pathway

(2011) A. Kovac et al.   JOURNAL OF IMMUNOLOGY

Advanced Glycation End Product Recognition by the Receptor for AGEs

(2011) Jing Xue et al.   STRUCTURE

Modulatory effects of vitamin E, acetyl-l-carnitine and α-lipoic acid on new potential biomarkers for Alzheimer's disease in rat model

(2010) Hanaa H. Ahmed   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Nuclear Tau, a Key Player in Neuronal DNA Protection

(2010) Audrey Sultan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia

(2010) A. Chan et al.   Journal of Nutrition Health & Aging

Oxidative stress in Alzheimer's disease hippocampus: A topographical study

(2010) F.F. Cruz-Sánchez et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

(2010) Lars M. Ittner et al.   NATURE REVIEWS NEUROSCIENCE

Alpha-tocopherol quinone inhibits beta-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines

(2010) Shi-gao Yang et al.   NEUROCHEMISTRY INTERNATIONAL

Aging and antioxidants modulate rat brain levels of homocysteine and dehydroepiandrosterone sulphate (DHEA-S): Implications in the pathogenesis of Alzheimer's disease

(2010) Maitrayee Sinha et al.   NEUROSCIENCE LETTERS

NIK and IKKβ interdependence in NF-κB signalling—Flux analysis of regulation through metabolites

(2009) Hong-Bum Kim et al.   BIOSYSTEMS

Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation

(2009) Francesc X. Guix et al.   BRAIN

Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT)☆

(2009) Tauheed Ishrat et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Atypical pathways of NF-κB activation and aging

(2009) Andres Kriete et al.   EXPERIMENTAL GERONTOLOGY

Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

(2009) Sandra L. Siedlak et al.   FREE RADICAL RESEARCH

Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease

(2009) Larry Baum et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease

(2009) Velandai Srikanth et al.   NEUROBIOLOGY OF AGING

Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus

(2009) Tony Valente et al.   NEUROBIOLOGY OF DISEASE

Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease

(2009) Manuela Padurariu et al.   NEUROSCIENCE LETTERS

Dietary supplementation with a combination of α-lipoic acid, acetyl-l-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance

(2009) James Suchy et al.   NUTRITION RESEARCH

Reactive oxygen species: Destroyers or messengers?

(2008) Grzegorz Bartosz   BIOCHEMICAL PHARMACOLOGY

High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease

(2008) Paul S. Aisen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

NFκB-dependent Control ofBACE1Promoter Transactivation by Aβ42

(2008) Virginie Buggia-Prevot et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation

(2008) Katrin Bigl et al.   JOURNAL OF NEURAL TRANSMISSION